EDSA · Edesa Biotech, Inc. · Fails to Deliver
$2.77
+0.01 (+0.36%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s ability to continue as a going concern is dependent on obtaining additional funding through financings, other strategic activities as well as via grants, to fund the development of its drug candidates. There can be no assurance that the Company will be successful in raising the necessary financing. These conditions indicate the existence of a material uncertainty that may cast substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$26.71M
Shares
9.64M
Volume · Oct 23
18.56K
Avg daily vol (3M)
60.35K
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 24 | $3.56 | $85 |
| 2026-09-25 | 635 | $4.03 | $2,559 |
| 2026-09-16 | 278 | $4.12 | $1,145 |
| 2026-09-10 | 4 | $4.72 | $19 |
| 2026-09-09 | 2,484 | $4.73 | $11,749 |
| 2026-09-08 | 1,799 | $4.73 | $8,509 |
| 2026-09-03 | 156 | $4.76 | $743 |
| 2026-09-02 | 677 | $4.78 | $3,236 |
| 2026-08-31 | 335 | $4.62 | $1,548 |
| 2026-08-27 | 4,786 | $4.94 | $23,643 |
| 2026-08-25 | 8 | $4.40 | $35 |
| 2026-08-24 | 1,397 | $4.43 | $6,189 |
| 2026-08-21 | 3,084 | $4.76 | $14,680 |
| 2026-08-19 | 124 | $5.71 | $708 |
| 2026-08-14 | 345 | $5.43 | $1,873 |
| 2026-08-03 | 801 | $5.11 | $4,093 |
Showing 1–16 of 16 settlements